These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 12661452)
1. [Tuberculosis and HIV coinfection in three patients: the possibilities for simultaneous treatment]. van Oosterhout JJ; Boeree MJ; Burger DM; de Lange WC; van Crevel R; Koopmans PP Ned Tijdschr Geneeskd; 2003 Mar; 147(9):369-72. PubMed ID: 12661452 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Burman WJ; Gallicano K; Peloquin C Clin Infect Dis; 1999 Mar; 28(3):419-29; quiz 430. PubMed ID: 10194057 [No Abstract] [Full Text] [Related]
3. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433 [TBL] [Abstract][Full Text] [Related]
4. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians. van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560 [TBL] [Abstract][Full Text] [Related]
5. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis. Manosuthi W; Ruxrungtham K; Likanonsakul S; Prasithsirikul W; Inthong Y; Phoorisri T; Sungkanuparph S Clin Infect Dis; 2007 Jan; 44(1):141-4. PubMed ID: 17143831 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771 [TBL] [Abstract][Full Text] [Related]
8. [Practice guideline prevention, diagnosis and treatment of tuberculosis in patients with an HIV infection]. van Leth F; Gebhart AC; van Altena R; Rijkeboer AA; Reusken AM; van Gerven PJ; Ned Tijdschr Geneeskd; 2009; 153():A1225. PubMed ID: 20482917 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Williams BG; Dye C Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302 [TBL] [Abstract][Full Text] [Related]
12. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. McIlleron H; Meintjes G; Burman WJ; Maartens G J Infect Dis; 2007 Aug; 196 Suppl 1():S63-75. PubMed ID: 17624828 [TBL] [Abstract][Full Text] [Related]
13. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB. TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607 [No Abstract] [Full Text] [Related]
14. HIV and tuberculosis: think local, act global. Street A Intern Med J; 2004 Apr; 34(4):150-2. PubMed ID: 15086693 [No Abstract] [Full Text] [Related]
15. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection. Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA; Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762 [TBL] [Abstract][Full Text] [Related]
16. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin. Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754 [TBL] [Abstract][Full Text] [Related]
17. Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: an observational study from North India. Sharma A; Wanchu A; Bansal V; Singh S; Varma S Indian J Pathol Microbiol; 2007 Oct; 50(4):905-7. PubMed ID: 18306602 [TBL] [Abstract][Full Text] [Related]
18. Paradoxical reaction in HIV and tuberculosis coinfection. Wanchu A; Sud A; Bambery P; Singh S J Assoc Physicians India; 2002 Apr; 50():588-9. PubMed ID: 12164417 [TBL] [Abstract][Full Text] [Related]
19. HIV infection and multidrug-resistant tuberculosis: the perfect storm. Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830 [TBL] [Abstract][Full Text] [Related]
20. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005. Pozniak AL; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB; HIV Med; 2005 Jul; 6 Suppl 2():62-83. PubMed ID: 16011537 [No Abstract] [Full Text] [Related] [Next] [New Search]